Clin2
NCT06867406Possibly a fitNot yet recruiting

Safety study of KPC000154 in healthy volunteers

Healthy Subjects、Lipid Metabolism

Treatments studied

Part of Hormones & metabolism clinical trials.

This trial tests a new tablet called KPC000154 in healthy people to see if it is safe and how the body handles it. It may help develop a treatment for conditions related to high cholesterol.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
92 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You must be between 18 and 55 years old.
  • You must be in good general health with no major medical conditions.
  • Your body mass index (BMI) must be between 19 and 26 for single-dose or 19 to 30 for multiple-dose parts.
  • Men must weigh at least 110 lbs (50 kg) and women at least 99 lbs (45 kg).
  • You cannot have taken any medications (including over-the-counter or supplements) within 2 weeks before the trial.
  • You must be willing to avoid alcohol, caffeine, smoking, and certain fruits (like grapefruit) during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06669429Recruiting· Phase 1
Safety study of RS-C1001 in healthy Chinese adults

This study tests a new medication called RS-C1001 in healthy Chinese volunteers to see if it's safe and how the body processes it. The drug may help lower cholesterol, but the main goal here is to check for side effects.

Beijing
NCT07752069Not yet recruiting· Phase 1
Comparing different versions of an experimental drug in healthy volunteers

This study tests different forms of an experimental medicine called HRS-5346 to see how the body absorbs them. It is for healthy people aged 18 to 45, and the results will help decide which version to use in future studies.

Beijing, Beijing Municipality
NCT07722299Not yet recruiting· Phase 1
Safety study of SAL0167 in healthy volunteers

This trial tests a new drug called SAL0167 in healthy people to see if it is safe and how the body processes it. The study has two parts: Part A includes all healthy volunteers, and Part B focuses on people with moderately high cholesterol.

Guangzhou, Guangdong
NCT07407634Not yet recruiting· Early Phase 1
Study of a new cholesterol-lowering tablet (XTYW007)

This study tests a new tablet (XTYW007) to see if it’s safe and helps lower cholesterol. It’s for people with certain LDL cholesterol levels and likely for those who have not responded well to standard treatments.

Jilin City, Changchun
NCT07074236Not yet recruiting· Phase 1
Study of a new cholesterol drug in healthy adults

This study tests how a new drug moves through the body and affects cholesterol levels. It is for people with moderately high cholesterol who are otherwise healthy.

Qingdao
NCT07777003Not yet recruiting· Phase 1
Study of a new drug for mild high cholesterol

This trial tests a new drug called HS-10582 in healthy people and those with slightly high LDL cholesterol (a type of cholesterol). The goal is to see if it is safe and how well your body handles it.

Hear when a new Healthy Subjects、Lipid Metabolism trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.